ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,392Medicare Part D Prescriptions Filled, Including Refills

Rank: 239 out of 939

$652K Total Retail Price of All Prescriptions

Rank: 149 out of 939

519 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 519 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

33% of this provider’s 519 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

5% of this provider’s 5,197 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 920 400 S3 1 1
LISINOPRIL 337 200 2 3
LEVOTHYROXINE SODIUM 287 181 3 4
AMLODIPINE BESYLATE 259 168 4 6
PRAVASTATIN SODIUM 205 155 5 13
FUROSEMIDE 203 129 6 7
GABAPENTIN 201 72 7 11
SIMVASTATIN 196 103 8 2
METFORMIN HCL 194 86 9 8
OMEPRAZOLE 160 94 10 5
CARISOPRODOL 158 25 R 11 51
POTASSIUM CHLORIDE 154 97 12 9
NEXIUM 143 61 13 18
TRAMADOL HCL 118 49 14 16
HYDROCHLOROTHIAZIDE 110 83 15 12
ZOLPIDEM TARTRATE 110 39 15 20
SERTRALINE HCL 105 42 17 24
CYCLOBENZAPRINE HCL 105 24 R 17 36
AMITRIPTYLINE HCL 100 77 R 19 38
OXYCODONE HCL 94 12 S2 20 67
METOPROLOL TARTRATE 93 30 21 10
CLOPIDOGREL 91 55 22 28
GLIPIZIDE 90 67 23 52
LISINOPRIL-HYDROCHLOROTHIAZIDE 89 51 24 23
DOXAZOSIN MESYLATE 85 67 25 108
GLIPIZIDE ER 84 51 26 88
PREDNISONE 81 30 27 42
PROAIR HFA 80 25 28 41
WARFARIN SODIUM 75 50 29 17
METOPROLOL SUCCINATE 70 26 30 21
PLAVIX 70 37 30 48
PROMETHAZINE HCL 69 20 R 32 68
CITALOPRAM HBR 69 39 32 15
CYMBALTA 68 14 34 44
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 38 35 64
CARVEDILOL 65 39 36 25
OXYCONTIN 65 13 S2 36 161
COMBIVENT 63 37 38 120
BUMETANIDE 62 24 39 124
CIPROFLOXACIN HCL 61 21 40 54
ATENOLOL 60 40 41 19
VERAPAMIL ER 60 53 41 85
FAMOTIDINE 59 24 43 62
MELOXICAM 58 39 44 14
AMLODIPINE BESYLATE-BENAZEPRIL 56 43 45 58
FLUOXETINE HCL 56 41 45 47
IBUPROFEN 56 0 45 112
TAMSULOSIN HCL 54 46 48 27
ATORVASTATIN CALCIUM 53 31 49 22
BUTORPHANOL TARTRATE 50 0 50 407
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.